A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234

Trial Identifier:	D8750C00008
Sponsor:	AstraZeneca
Collaborator:	Quotient Sciences Limited
Start Date:	November 2025
Primary Completion Date:	March 2026
Study Completion Date:	March 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Ruddington, GB, NG11 6JS

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.